Exclusive androgenic effect of dehydroepiandrosterone in sebaceous glands of rat skin.
In order to analyze the hormonal effects of dehydroepiandrosterone (DHEA) in skin sebaceous glands, the precursor steroid was administered to ovariectomized (OVX) female Sprague-Dawley rats at a dose of 30 mg applied on the dorsal skin, twice daily, for 3, 6 and 12 months. In a parallel experiment, female OVX rats were treated with DHEA at the same daily percutaneous dose of 30 mg, alone or in combination with the antiandrogen Flutamide or the pure antiestrogen EM-800, for 12 months, in order to determine the androgenic and/or estrogenic components of DHEA action. Treatment of female OVX rats with DHEA resulted in a similar mild to moderate hyperplasia of the sebaceous glands of both dorsal (site of application) and ventral skin, as illustrated by an increase in the number and size of the acini. The above-indicated effects were observed at all time intervals studied, beginning at 3 months of treatment, and they were not further increased after longer term administration of DHEA (for 6 and 12 months). The addition of Flutamide to DHEA treatment completely prevented the DHEA-induced changes in the sebaceous glands, whereas the antiestrogen EM-800 had no effect. The present data indicate an exclusive androgenic stimulatory action of DHEA on the sebaceous glands, thus pointing out the importance of local intracrine DHEA transformation into androgens for skin anatomical integrity and function, while showing that estrogens, if active in rat skin, do not originate from DHEA.
Sourla
A
A
Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec (CHUQ), CHUL Pavilion, Department of Medicine and Laval University, Québec, Québec G1V 4G2, Canada.
Richard
V
V
Labrie
F
F
Labrie
C
C
D000279:Administration, Cutaneous; D000726:Androgen Antagonists / Q000494:pharmacology; D000818:Animals; D001578:Benzopyrans / Q000494:pharmacology; D003687:Dehydroepiandrosterone / Q000494:pharmacology*; D020847:Estrogen Receptor Modulators / Q000494:pharmacology; D005260:Female; D005485:Flutamide / Q000494:pharmacology; D006965:Hyperplasia; D023421:Models, Animal; D010052:Ovariectomy; D011422:Propionates / Q000494:pharmacology; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D012627:Sebaceous Glands / Q000187:drug effects* / Q000473:pathology; D013268:Stimulation, Chemical; D013997:Time Factors
D000726:Androgen Antagonists; D001578:Benzopyrans; D020847:Estrogen Receptor Modulators; D011422:Propionates; D003687:Dehydroepiandrosterone; D005485:Flutamide; C106945:EM 800